Heart transplant monitoring with extracellular vesicles
Part of Heart & circulation clinical trials.
This study uses tiny particles called extracellular vesicles (which cells release) to check for signs of organ rejection after a heart transplant, aiming for a safer and less invasive alternative to biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are on the heart transplant waiting list or have just had a heart transplant
- You are 18 years or older
- You can understand the study and give written permission to join
- If you are a woman who could become pregnant, you must have a negative pregnancy test before starting
- You have not had any other organ or tissue transplants before
- You are not legally detained or unable to follow study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced heart imaging and blood tests to detect a type of rejection that can happen after a heart transplant. It may help doctors diagnose antibody-mediated rejection earlier and more accurately.
This study tests a new way to monitor heart transplant patients for rejection using blood tests and other non-invasive tools, which might reduce the need for invasive biopsies. If you've had a recent heart transplant and are stable, this study could help improve post-transplant care.
This trial is studying whether a blood test that measures small molecules called microRNAs can help doctors personalize the medicines used to prevent rejection after a heart transplant. If you qualify, you would help researchers learn how to better match immunosuppression to each patient's needs.
This study looks at whether changes in blood fats (cholesterol and triglycerides) after a heart transplant are linked to the risk of organ rejection. It may help doctors better monitor and protect your new heart.
This study tests a new approach to managing anti-rejection medicines after a heart transplant. It uses special blood tests to see if your immune system is calm, so doctors can safely reduce the medicines and lower side effects.
This trial tests a special machine that preserves donor hearts for longer periods before transplant. It may help people waiting for a heart transplant who need a heart from a donor that may be older or has some heart risks.
Hear when a new Rejection Heart Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.